Researchers & Clinicians
The experts actively authoring scientific papers and overseeing clinical trials in psychedelic research.
51 researchers
Stefan Borgwardt
Chair of Psychiatry and Psychotherapy at the University of Lübeck
Patrick C. Dolder
Pharmacology Researcher at Maastricht University
Robin Carhart-Harris
Ralph Metzner Distinguished Professor
José Carlos Bouso
Scientific Director at ICEERS Foundation
Rick Doblin
Founder and President of MAPS
Jaime Eduardo Cecílio Hallak
Full Professor of Psychiatry at the University of São Paulo
David Erritzoe
Clinical Associate Professor in Psychopharmacology
Amanda Feilding
Executive Director and Founder
Luis Fernando Tófoli
Professor of Psychiatry at UNICAMP, Brazil
Patrick Fisher
Senior Researcher in Neurobiology at Copenhagen University Hospital
Albert Garcia-Romeu
Associate Professor at Johns Hopkins University School of Medicine
Roland Griffiths
Professor of Neuroscience and Psychiatry
Rafael Guimarães dos Santos
Professor of Pharmacology at University of São Paulo
Katrin H. Preller
Visiting Assistant Professor at Yale and Researcher at University of Zurich
Friederike Holze
Postdoctoral Fellow at Copenhagen University Hospital
Lisa Jerome
Clinical Research Specialist at MAPS PBC
Alan K. Davis
Associate Professor & Director of the Center for Psychedelic Drug Research and Education at OSU
Mendel Kaelen
Founder and CEO of Wavepaths, Neuroscientist
Hannes Kettner
Research Specialist at UCSF and PhD Candidate at Imperial College London
Gitte Knudsen
Professor of Neurology at Copenhagen University Hospital
Natasha Leigh Mason
Assistant Professor of Neuropsychology and Psychopharmacology
Matthias Liechti
Professor of Clinical Pharmacology
Sanjay Mathew
Vice Chair for Research at Baylor College of Medicine
Roger McIntyre
Professor of Psychiatry and Pharmacology at the University of Toronto
Michael Mithoefer
Senior Medical Director for Medical Affairs at MAPS PBC
Suresh Muthukumaraswamy
Associate Professor of Pharmacy at the University of Auckland
Felix Müller
Project Leader in Clinical Research at University of Basel
David Nutt
Edmond J. Safra Professor of Neuropsychopharmacology
David Olson
TBD
Kim P.C. Kuypers
Associate Professor of Neuropsychology and Psychopharmacology
Fernanda Palhano-Fontes
Research Engineer at the Brain Institute, UFRN
Johannes Ramaekers
Professor of Psychopharmacology
Jordi Riba
Pioneer Researcher in Ayahuasca Pharmacology (1968-2020)
Fernando Rosas
Lecturer in Informatics and Complexity Science
Leor Roseman
Senior Lecturer and Psychedelic Researcher
James Rucker
Senior Clinical Lecturer at King's College London
Frederick S. Barrett
Director of the Johns Hopkins Center for Psychedelic and Consciousness Research
Peter S. Hendricks
Professor of Psychiatry and Behavioral Neurobiology at UAB
Milan Scheidegger
Leader of Psychedelic Research at University of Zurich
Yasmin Schmid
Senior Attending Physician at University Hospital Basel
Erich Seifritz
Director of the Clinic for Affective Disorders at the University of Zurich
Otto Simonsson
Researcher in Clinical Neuroscience at Karolinska Institute
Enzo Tagliazucchi
Director of the Laboratory of Consciousness at University of Buenos Aires
Christopher Timmermann
Co-director of the UCL Centre for Consciousness Research
Patrick Vizeli
Postdoctoral Researcher in Clinical Pharmacology
Franz Vollenweider
Professor Emeritus of Psychiatry
Matthew W. Johnson
Professor of Psychiatry
Berra Yazar-Klosinski
CEO of Yazar Lab, Former CSO at Lykos Therapeutics
Carlos Zarate Jr.
Chief of Experimental Therapeutics at NIMH
Richard Zeifman
Assistant Professor of Psychology and Director of PATH Lab
Harriet de Wit
Professor of Psychiatry at the University of Chicago